EA
ACAD icon

Emerald Acquisition’s Acadia Pharmaceuticals ACAD Stock Holding History

Emerald Acquisition’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$267K Sell
8,396
-36,968
-81% -$1.25M ﹤0.01% 2627
2016
Q2 		$1.47M Buy
+45,364
New +$1.52M ﹤0.01% 1973

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Acquisition's ACAD Position: Q3 2016 in Review

Emerald Acquisition reduced its Acadia Pharmaceuticals (ACAD) stake by 81% in Q3 2016, selling an estimated $1.25M and leaving 8,396 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

Emerald Acquisition first reported a position in ACAD in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.47M in Q2 2016. 232 funds tracked by Wall St. Rank hold ACAD as of Q3 2016.

  • Emerald Acquisition held 8,396 shares of Acadia Pharmaceuticals worth $267K as of Q3 2016.
  • Emerald Acquisition sold 36,968 Acadia Pharmaceuticals shares in Q3 2016, an estimated $1.25M.
  • Acadia Pharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2627 holding.
  • Emerald Acquisition first reported a position in Acadia Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Acadia Pharmaceuticals position peaked at $1.47M in Q2 2016.
  • 232 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.